Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys

Journal of the National Cancer Institute

Volumn 89, Issue 21, 1997, Pages 1602-1608

  Olivero, Ofelia A ^a,f   Anderson, Lucy M ^b   Diwan, Bhalchandra A ^c   Haines, Diana C ^c   Harbaugh, Steven W ^d   Moskal, Thomas J ^d   Jones, Ann B ^b   Rice, Jerry M ^e   Riggs, Charles W ^a   Logsdon, Daniel ^c   Yuspa, Stuart H ^a   Poirier, Miriam C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^d BIOQUAL INC   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DNA BINDING; DRUG EFFECT; FEMALE; FETUS; FETUS DISEASE; GENOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; MALIGNANT NEOPLASTIC DISEASE; MONKEY; MOUSE; NEWBORN; NEWBORN DISEASE; NONHUMAN; PREGNANCY; TRANSPLACENTAL CARCINOGENESIS; VIRUS INHIBITION; VIRUS TRANSMISSION;

EID: 0030715604     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.21.1602     Document Type: Article

References (39)

1. Napalkov MP, Rice JM, Tomatis L, Yamasaki H, editors. Perinatal and multigeneration carcinogenesis. Lyon, France: IARC, 1989.
2. Herbst AL, Ulfelder H, Poskanzer DC. Adeno-carcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284: 878-81.
3. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 1995;103 Suppl 7: 83-7.
4. Zahm SH, Devesa SS. Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect 1995; 103 Suppl 6:177-84.
5. Savitz DA, Chen JH. Parental occupation and childhood cancer: review of epidemiologic studies. Environ Health Perspect 1990;88: 325-37.
6. Bunin GR, Rose PG, Noller KL, Smith E. Occupational and environmental reproductive hazards. In: Paul M, editor. A guide for clinicians. Baltimore (MD): Williams & Wilkins, 1993:76-88.
7. Anderson LM, Donovan PJ, Rice JM. Risk assessment for transplacental carcinogenesis. In: Li AP, editor. New approaches in toxicity testing and their application in human risk assessment. New York: Raven Press, 1985: 179-202.
8. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
9. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335: 1621-9.
10. Retrovir. In: Physicians' desk reference. Mont-vale (NJ): Medical Economics Co., 1997: 1216-25.
11. Ayers KM, Clive D, Tucker WE Jr, Hajian G, De Miranda P. Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fundam Appl Toxicol 1996;32:148-58.
12. Toxicology and carcinogenesis studies of AZT. Research Triange Park (NC): National Toxicology Program, 1996.
13. Olivero OA, Beland FA, Fullerton NF, Poirier MC. Vaginal epithelial DNA damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of 3′-azido-2′,3′-dideoxythymidine. Cancer Res 1994;54:6235-42.
14. Armitage P. Statistical methods in medical research. Oxford, England: Blackwell Scientific Publications, 1971:362-7.
15. Colquhoun D. Lectures on biostatistics. Oxford, England: Clarendon Press, 1971: 116-23.
16. Snedecor GW, Cochran WG. Statistical methods, sixth edition. Ames (IA): Iowa State University Press, 1967:215-21.
17. Tarone RE. Testing the goodness of fit of the binomial distribution. Biometrika 1979;66: 585-90.
18. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist 1950;21:607-11.
19. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley and Sons, 1973:120-3.
20. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley and Sons, 1973:67-74.
21. Tamura K, Aotsuka T. Rapid isolation method of animal mitochondrial DNA by the alkaline lysis procedure. Biochem Genet 1988;26: 815-9.
22. Olivero OA, Beland FA, Poirier MC. Immunofluorescent localization and quantitation of 3′-azido-2′,3′-dideoxythymidine (AZT) incorporated into chromosomal DNA of human, hamster and mouse cell lines. Int J Oncol 1994; 4:49-54.
23. Lu LJ, Anderson LM, Jones AB, Moskal TJ, Salazar JJ, Hokanson JA, et al. Persistence, gestation stage-dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys. Carcinogenesis 1993;14:1805-13.
24. Gomez DE, Kassim A, Olivero OA. Preferential incorporation of 3′-azido-2′,3′-dideoxythymidine (AZT) in telomeric sequences of CHO cells. Int J Oncol 1995;7:1057-60.
25. Maniatis TE, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1982.
26. Percy DH, Jonas AM. Incidence of spontaneous tumors in CD (R) -1 HaM-ICR mice. J Natl Cancer Inst 1971;46:1045-65.
27. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
28. Gomez DE, Olivero OA. Long-term AZT (3′-azido-2′,3′-dideoxythymidine) treatment shortens the telomeric sequences of HeLa cells in culture [abstract]. Proc Am Assoc Cancer Res 1996;36:abstract 3848.
29. Anderson LM, Hagiwara A, Kovatch RM, Rehm S, Rice JM. Transplacental initiation of liver, lung, neurogenic, and connective tissue tumors by N-nitroso compounds in mice. Fundam Appl Toxicol 1989;12:604-20.
30. Anderson LM, Ruskie S, Carter J, Pittinger S, Kovatch RM, Riggs CW. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 7,12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Pharmacogenetics 1995;5:364-72.
31. Anderson LM, Jones AB, Riggs CW, Ohshima M. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis 1985;6:1389-93.
32. Anderson LM, Hecht SS, Dixon DE, Dove LF, Kovatch RM, Amin S, et al. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Cancer Res 1989;49:3770-5.
33. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 1966;50:219-44.
34. Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clercq E, Broder S, et al. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 1988;37:897-903.
35. Bilello JA, MacAuley C, Fredrickson TN, Bell MM, McKissick C, Shapiro SG, et al. Use of a neonatal murine retrovirus model to evaluate the long-term efficacy and toxicity of antiviral agents. Ann N Y Acad Sci 1990;616: 238-51.
36. Bilello JA, Eiseman JL, Standiford HC, Drusano GL. Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy. Antimicrob Agents Chemother 1994;38:628-31.
37. Ayers KM, Torrey CE, Reynolds DJ. A trans-placental carcinogenicity bioassay in CD-1 mice with Zidovudine. Fundam Appl Toxicol 1997;38:195-8.
38. Yuspa SH, Poirier MC. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res 1988;50: 25-70.
39. Greenwald P, Malone WF, Cerny ME, Stern HR. Cancer prevention research trials. Adv Cancer Res 1993;61:1-23.